Literature DB >> 2373474

Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B.

G Yamada1, K Takaguchi, K Matsueda, H Nishimoto, M Takahashi, S Fujiki, M Mizuno, S Kinoyama, T Tsuji.   

Abstract

Immune light and electron microscopic studies using monoclonal antibodies have been applied to localize HBeAg in liver biopsy specimens of 19 patients with chronic hepatitis B. Under the light microscope, HBeAg was demonstrated in nuclei, cytoplasm and on the cell surface of hepatocytes. The number of HBeAg-positive hepatocytes correlated well with the serum levels of HBeAg (enzyme immunoassay) and DNA-polymerase. Of 11 patients in whom high numbers of HBeAg-positive hepatocytes were found at the light microscopic level, HBeAg was also studied in hepatocytes at the electron microscopic level. The HBeAg in nuclei was either found as aggregates or dispersed diffusely. In the aggregates of HBeAg, the 27-nm core particles were frequently found. In addition, the antigen was found in the cytosol of some hepatocytes as amorphous mass and in some hepatocytes in the cisternae of perinuclear space, endoplasmic reticulum and Golgi saccules. Occasionally the antigen was found on the membranes of the cell organelles and on the plasma membranes that faced the intercellular and the Disse spaces. These findings suggest that cytoplasmic HBeAg in hepatocytes may be ultrastructurally classified into two different patterns by its distribution, mainly in endoplasmic reticulum or in cytosol. The ratio varied between hepatocytes with these two types of patterns. The titer of serum HBeAg tended to be higher when the corresponding liver biopsy specimens contained more hepatocytes with HBeAg in endoplasmic reticulum than those with HBeAg in the cytosol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373474     DOI: 10.1002/hep.1840120121

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

4.  Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.

Authors:  M L Campillo; J A Quiroga; J Bartolomé; G Moraleda; I Castillo; V Carreño
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Localization of hepatitis C viral RNA and capsid protein in human liver.

Authors:  G Yamada; H Nishimoto; H Endou; T Doi; M Takahashi; T Tsuji; H Yoshizawa; M Nozawa; T Koji; P K Nakane
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Electron microscopic study of hepatitis B virus-associated antigens on the infected liver cell membrane in relation to analysis of immune target antigens in chronic hepatitis B.

Authors:  T Saito; T Kamimura; M Ishibashi; H Shinzawa; T Takahashi
Journal:  Gastroenterol Jpn       Date:  1992-12

7.  Immunohistochemical study of the distribution of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in chronic type B hepatitis.

Authors:  T Doi; G Yamada; M Mizuno; T Tsuji
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

8.  In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion.

Authors:  Aurélie Deroubaix; Anna Kramvis
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.